The FDA has announced an upcoming meeting on stem cells. From the federal register…
"On April 10, 2008, the committee will meet to discuss scientific considerations for safety testing for cellular therapy products derived from human embryonic stem cells. On April 11, 2008,
the committee will meet to discuss updates on the following topics: (1) Research management related to the September 29, 2005, review of research programs of the Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research; (2) FDA’s Somatic Cell
Therapy Letter; and (3) recently released FDA guidance documents. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. "
NOTE – This posting was republished to include the link to the Federal Register notice about the Stem Cell Meeting coming in April.